Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

Core Insights - Alector, Inc. is a clinical-stage biotechnology company focused on immuno-neurology, targeting immune dysfunction as a root cause of neurodegenerative diseases [1][2] - The company is hosting a virtual event to discuss its proprietary blood-brain barrier (BBB) technology platform, Alector Brain Carrier, and its application in next-generation product candidates [1] - The event will feature insights from Alector's management and a leading scientific expert, Dr. Zhiqiang An, on emerging technologies for BBB modulation [1] Company Overview - Alector is headquartered in South San Francisco, California, and is developing a broad portfolio of innate immune system programs aimed at treating neurodegenerative diseases such as Alzheimer's and genetically defined frontotemporal dementia [2] - The company's approach involves repairing genetic mutations that cause dysfunction in the brain's immune system, enabling rejuvenated immune cells to address emerging biomarkers [2] Event Details - The virtual event titled "Crossing the Blood-Brain Barrier: Advancing the Next Generation of Alector Neurodegenerative Therapies" is scheduled for June 18, 2024, from 3:00 pm to 4:30 pm EDT [1] - A live question and answer session will follow the formal presentation, and an archived replay will be available for approximately 90 days post-event [1]